Introduction {#s0005}
============

Human lifespan is influenced by multiple determinants, including various environmental and genetic factors. Though the non-genetic factors, such as diet, health habits, physical activity, and psychosocial factors are important, the role of heritability in determining human lifespan is attracting more and more attention. Age at death in adulthood has a heritability of approximately 25% ([@bb0070]), and the heritability of living to at least 100, i. e. centenarians, has been estimated at 0.33 in women and 0.48 in men ([@bb0105]). Epidemiological investigations reveal that the oldest old and their offspring usually have a delayed or reduced prevalence of age-related diseases, such as cardiovascular disease (CVD), Alzheimer Disease (AD), Parkinson Disease (PD), cancers and some metabolic diseases ([@bb0020], [@bb0035], [@bb0130], [@bb0135]), suggesting that the long-lived individuals may have some special genetic basis to help them to delay or escape these senile diseases.

In the past decade, a number of genes, e.g. *daf-2*, *daf-16* and *sir-2*, were discovered, in which some specific genetic alterations confer advantage in extending the organisms\' lifespan ([@bb0045], [@bb0050], [@bb0140]), indicating the existence of longevity genes. Only very few longevity genes are confirmed to be valid for human beings ([@bb0015]), which is difficult to explain the significantly reduced incidence of age-related diseases in the longevity subjects and their offspring. Alternatively, given the recognition that all common complex diseases increase with age, it is plausible that the low prevalence of age-related diseases in the long-lived people is attributed to a much lower frequency of risk alleles. Indeed, there is increasing evidence showing a lower frequency of disease risk alleles in the longevity subjects ([@bb0075], [@bb0090], [@bb0100]). However, inconsistent observation comes from a recent study on the age-related disease risk variants in the longevity subjects ([@bb0010]), causing it highly controversial whether the long-lived people do contain a lower frequency of disease risk alleles. To provide more evidence, we selected 23 age-related disease risk variants with high prevalence and mortality rates in the elderly and had them genotyped in 1074 samples consisting of 574 longevity subjects (over 90 years) and 500 younger controls for the study. Our study reveals that the SNPs related to cardiovascular disease (CVD) show a much lower frequency in the longevity individuals than the controls, suggesting that the lack/scarcity of disease gene mutations could be a genetic contributor to longevity.

Methods {#s0010}
=======

Subjects {#s0015}
--------

total of 1074 Chinese subjects consisting of 574 longevity subjects (over 90 years, mean age 93.8 years) and 500 controls (mean age 51.7 years) were collected from Sichuan province of China in 2010. All of the longevity subjects had no severe life-threatening illness, such as heart attack, cerebellar hemorrhage, and cancer, according to the medical examination. Only some of them had decreased vision or hearing loss as reported previously ([@bb0030], [@bb0165]). The control subjects were all healthy with no severe medical history. Blood samples for DNA isolation were obtained after a 12 h fasting period. The investigation conformed with the principles outlined in the Declaration of Helsinki. The study protocol was approved by the Ethics Committee at Kunming Institute of Zoology, Chinese Academy of Sciences. Written informed consent was obtained from each of the participants prior to the study.

Choice of SNPs, DNA isolation and genotyping {#s0020}
--------------------------------------------

The age-related diseases with high prevalence and mortality rate based on the surveys and statistics of the World Health Organization (WHO) are considered in the present study, and as a result 23 risk SNPs were chosen from the GWAS database (Table S1). The SNPs were selected according to the following criteria: 1) minor allele frequency (MAF) in Chinese populations ≥ 20% according to HapMap data in Chinese Han Beijing ([Table S2](#ec0010){ref-type="supplementary-material"}, [Table S3](#ec0015){ref-type="supplementary-material"}); 2) the SNPs were either C/T or A/G which is for being compatible with the genotyping system used (Beckman Coulter, Fullerton, CA, USA); and 3) SNPs located no matter where they are (coding gene, outside or in intronic regions). Total genomic DNA was isolated from peripheral EDTA blood samples using a standard phenol/chloroform method ([@bb0095]). Multiplex polymerase chain reaction (PCR) and SNP analyses were performed using the GenomeLab SNPstream Genotyping System (Beckman Coulter, Fullerton, CA) following the protocols as described by [@bb0145]. Primers were optimally designed using a web-based software provided by Beckman Coulter (available at [www.autoprimer.com](http://www.autoprimer.com){#ir0015}) and were listed in [Table S4](#ec0015){ref-type="supplementary-material"}.

Statistical analysis {#s0025}
--------------------

Differences in the genotypes and alleles between the longevity and control groups were compared using an online platform SHEsis (<http://analysis.bio-x.cn>) ([@bb0120]). For those SNPs with significantly different genotypic distributions, the χ^2^ test was further used to analyze their associations with longevity by calculating the odds ratios (ORs). Bonferroni correction method for multiple comparisons was used where necessary. The significance threshold was set to observe P-value/number of comparisons ([@bb0065]). For each polymorphism, the Hardy--Weinberg equilibrium was calculated using the gene-counting method, and differences were assessed using the χ^2^ test. Statistical analyses were performed using SPSS statistical software version 13.0 (Beijing Stats Data Mining Co. Ltd.). P values less than 0.05 were considered statistically significant.

Results and discussion {#s0030}
======================

Human longevity is a complex phenotype with strong genetic predisposition. Based on the fact that the longevity individuals have a delayed or reduced prevalence of age-related diseases, we determined 23 SNPs in the longevity people over 90 years old. The selected SNPs are mainly focused on the age-related diseases with high prevalence, morbidity and mortality rates, such as CVD, cancers, neurodegenerative disorders, type 2 diabetes, hypertension and stroke (Table S1). After genotyping these SNPs, we identified 5 SNPs showing lower allelic frequencies and ORs in the longevity subjects than the controls, i.e. rs2144300, rs1864163, rs2200733, rs1967017, and rs7193343 ([Table 1](#t0005){ref-type="table"}). Of them, the SNPs rs2144300, rs1864163, and rs1967017 were reported to be associated with CVD ([@bb0005], [@bb0150], [@bb0160]); the SNPs rs2200733 and rs7193343 are the risk factors of ischemic stroke ([@bb0025], [@bb0115]). For genotypic distribution, our study observed 8 SNPs (rs501120, rs2144300, rs1864163, rs2200733, rs127430, rs1967017, rs7193343, and rs12413409) with significant differences between the longevity and control groups ([Table 2](#t0010){ref-type="table"}). Further analysis showed that the SNPs rs1864163, rs2200733, rs127430, rs1967017, and rs12413409 had lower homozygous genotype frequencies and ORs in the longevity subjects than the controls ([Table 3](#t0015){ref-type="table"}). Except for the SNPs (rs1967017, rs1864163, and rs2200733) indicated above, the rs127430 and rs12413409 are also two risk factors predisposing to CVD/myocardial infarction ([@bb0085], [@bb0125]). In addition, the SNPs rs501120, rs2144300 and rs7193343 had lower frequencies of independent heterozygous genotype or a combination of heterozygous and homozygous genotypes as well as their corresponding ORs compared to the wild genotypes. Surprisingly, these 3 SNPs were also closely associated with CVD or stroke ([@bb0005], [@bb0025], [@bb0080]).

In agreement with the previous studies ([@bb0010], [@bb0060], [@bb0110]), most of the SNPs considered here, such as type 2 diabetes and cancers, showed no distribution difference between the longevity and the younger controls. However, our results revealed that the risk SNPs with significantly lower frequencies in longevity cases were all related to vascular diseases, especially the CVD which is the leading cause of deaths worldwide in the elderly ([@bb0055], [@bb0155]). Consistently, Pinos et al. reported that rs1333049, a polymorphism which is closely associated with coronary artery disease (CAD), showed a lower risk allelic frequency in Southern European centenarians as well. Although inconsistent result did have been reported elsewhere ([@bb0010]), the proportion of selected CVD risk SNPs or different genetic backgrounds may account for the discrepancy. Nevertheless, taking into account our current results that longevity individuals lack or have infrequent risk alleles associated with the CVD, as well as the observation that the oldest old and their offspring have lower cardiovascular mortality ([@bb0130], [@bb0135]), it is then most plausible that the lack of age-related disease risk variants, especially the CVD, serves as the genetic contributor to longevity in the Chinese population.

The limitation that should be noted is that some SNPs with significant association to phenotypes do not obey Hardy--Weinberg equilibrium, which may be caused by the assay nonspecificity or genotyping errors for the SNP ([@bb0040]), however, which does not affect the conclusion due to that the remaining significant SNPs were in Hardy--Weinberg equilibrium and highly associated with the age-related diseases, especially the CVD. In addition, due to that the genotyping system can only recognize the C/T or A/G mutations, those SNPs with other mutation types were excluded from genotyping, so the criterion of SNP selection is another limitation for this study.

In conclusion, we genotyped 23 SNPs associated with age-related diseases in the longevity subjects, and found that the longevity individuals did lack some age-related disease risk variants, especially the CVD, which may contribute to longevity in the Chinese population.

The following are the Supplementary data related to this article.Table S1. Selected loci associated with age-related diseases from the GWAS database. Table S4. Primers used for multiplex polymerase chain reaction (PCR) and SNP analyses..Table S2Hapmap allele frequency data of selected SNPs.Table S3Hapmap genotype frequency data of selected SNPs.
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###### 

Allelic distributions of selected SNPs in the control and longevity subjects.

               Control       Control number   Longevity   Longevity number   Allelic analysis                                         
  ------------ ------------- ---------------- ----------- ------------------ ------------------ ----- -------- ------- -------------- ----------------
  rs4689388    920 (0.926)   74 (0.074)       497         1059 (0.926)       85 (0.074)         572   0.000    0.998   0.722--1.379   0.990
  rs12425791   743 (0.749)   249 (0.251)      497         861 (0.753)        283 (0.247)        572   0.037    0.981   0.806--1.193   0.847
  rs401681     308 (0.310)   686 (0.690)      497         395 (0.345)        749 (0.655)        572   3.024    0.851   0.710--1.021   0.082
  rs2075650    81 (0.082)    911 (0.918)      497         104 (0.091)        1040 (0.909)       572   0.575    0.889   0.656--1.204   0.448
  rs10821936   616 (0.620)   378 (0.380)      497         709 (0.620)        435 (0.380)        572   0.000    0.999   0.839--1.191   0.999
  rs2300747    413 (0.415)   581 (0.585)      497         486 (0.425)        658 (0.575)        572   0.190    0.962   0.810--1.143   0.663
  rs501120     356 (0.358)   638 (0.642)      497         403 (0.352)        741 (0.648)        572   0.080    1.026   0.859--1.225   0.777
  rs2383208    447 (0.450)   547 (0.550)      497         502 (0.439)        642 (0.561)        572   0.255    1.045   0.881--1.240   0.613
  rs6532197    671 (0.675)   323 (0.325)      497         790 (0.691)        354 (0.309)        572   0.591    0.931   0.776--1.117   0.442
  rs947211     457 (0.460)   537 (0.540)      497         482 (0.421)        662 (0.579)        572   3.189    1.169   0.985--1.387   0.074
  rs8034191    952 (0.958)   42 (0.042)       497         1099 (0.961)       45 (0.039)         572   0.116    0.928   0.604--1.426   0.733
  rs17319721   898 (0.903)   96 (0.097)       497         1035 (0.905)       109 (0.095)        572   0.010    0.985   0.738--1.315   0.919
  rs2144300    741 (0.747)   251 (0.253)      500         941 (0.820)        207 (0.180)        574   16.725   0.649   0.528--0.799   4.37 × 10^− 5^
  rs1864163    840 (0.845)   154 (0.155)      500         1010 (0.880)       138 (0.120)        574   5.455    0.745   0.582--0.954   0.020
  rs2200733    411 (0.459)   485 (0.541)      500         598 (0.521)        550 (0.479)        574   7.789    0.779   0.654--0.929   0.005
  rs1735151    422 (0.422)   578 (0.578)      500         450 (0.392)        698 (0.608)        574   1.996    1.132   0.953--1.346   0.158
  rs1902341    327 (0.328)   669 (0.672)      500         383 (0.334)        765 (0.666)        574   0.068    0.976   0.815--1.169   0.794
  rs127430     352 (0.352)   648 (0.648)      500         428 (0.373)        720 (0.627)        574   1.002    0.914   0.766--1.090   0.317
  rs1967017    667 (0.671)   327 (0.329)      500         861 (0.750)        287 (0.250)        574   16.249   0.679   0.563--0.821   5.61 × 10^− 5^
  rs11775334   771 (0.672)   377 (0.328)      500         644 (0.644)        356 (0.356)        574   1.811    0.885   0.739--1.058   0.178
  rs7193343    630 (0.636)   360 (0.364)      500         780 (0.679)        368 (0.321)        574   4.393    0.826   0.690--0.988   0.036
  rs12413409   585 (0.589)   409 (0.411)      500         719 (0.626)        429 (0.374)        574   3.192    0.853   0.717--1.016   0.074
  rs10953541   820 (0.828)   170 (0.172)      500         986 (0.859)        162 (0.141)        574   3.795    0.793   0.627--1.002   0.051

A, wild allele; B, disease risk allele; OR, odds ratio; 95% CI, 95% confidence interval; the number in parenthesis means the frequency of alleles.

###### 

Genotypic distributions of selected SNPs in the control and longevity subjects.

               Control       Control number   Longevity     Longevity number   χ^2^          P value                                    
  ------------ ------------- ---------------- ------------- ------------------ ------------- ------------- ------------- ----- -------- ----------------
  rs4689388    424 (0.853)   72 (0.145)       1 (0.002)     497                490 (0.857)   79 (0.138)    3 (0.005)     572   0.833    0.660
  rs12425791   271 (0.546)   201 (0.405)      24 (0.048)    497                322 (0.563)   217 (0.379)   33 (0.058)    572   1.017    0.602
  rs401681     41 (0.082)    226 (0.455)      230 (0.463)   497                66 (0.115)    263 (0.460)   243 (0.425)   572   3.755    0.153
  rs2075650    473 (0.827)   94 (0.164)       5 (0.009)     497                4 (0.008)     73 (0.147)    419 (0.845)   572   0.616    0.735
  rs10821936   175 (0.352)   266 (0.535)      56 (0.113)    497                213 (0.372)   283 (0.495)   76 (0.133)    572   2.026    0.363
  rs2300747    75 (0.151)    263 (0.529)      159 (0.320)   497                96 (0.168)    294 (0.514)   182 (0.318)   572   0.597    0.742
  rs501120     44 (0.089)    268 (0.539)      185 (0.372)   497                83 (0.145)    237 (0.414)   252 (0.441)   572   18.983   7.55 × 10^− 5^
  rs2383208    81 (0.163)    285 (0.573)      131 (0.264)   497                98 (0.171)    306 (0.535)   168 (0.294)   572   1.686    0.430
  rs6532197    209 (0.421)   253 (0.509)      35 (0.070)    497                265 (0.463)   260 (0.455)   47 (0.082)    572   3.222    0.200
  rs947211     84 (0.169)    289 (0.581)      124 (0.249)   497                81 (0.142)    320 (0.559)   171 (0.299)   572   3.878    0.144
  rs8034191    455 (0.915)   42 (0.085)       0 (0.000)     497                529 (0.925)   41 (0.072)    2 (0.003)     572   2.327    0.312
  rs17319721   406 (0.817)   86 (0.173)       5 (0.010)     497                466 (0.815)   103 (0.180)   3 (0.005)     572   0.901    0.638
  rs2144300    268 (0.540)   205 (0.413)      23 (0.046)    500                386 (0.672)   169 (0.294)   19 (0.033)    574   19.555   5.67 × 10^− 5^
  rs1864163    370 (0.744)   100 (0.201)      27 (0.054)    500                445 (0.775)   120 (0.209)   9 (0.016)     574   12.247   0.002
  rs2200733    109 (0.243)   193 (0.431)      146 (0.326)   500                163 (0.284)   272 (0.474)   139 (0.242)   574   8.915    0.012
  rs1735151    75 (0.150)    272 (0.544)      153 (0.306)   500                64 (0.111)    322 (0.561)   188 (0.328)   574   3.589    0.166
  rs1902341    53 (0.106)    221 (0.444)      224 (0.450)   500                67 (0.117)    249 (0.434)   258 (0.449)   574   0.313    0.855
  rs127430     39 (0.078)    274 (0.548)      187 (0.374)   500                78 (0.136)    272 (0.474)   224 (0.390)   574   11.293   3.53 × 10^− 3^
  rs1967017    301 (0.606)   65 (0.131)       131 (0.264)   500                413 (0.720)   35 (0.061)    126 (0.220)   574   21.239   2.44 × 10^− 5^
  rs11775334   220 (0.440)   204 (0.408)      76 (0.152)    500                261 (0.455)   249 (0.434)   64 (0.111)    574   3.913    0.141
  rs7193343    179 (0.362)   272 (0.549)      44 (0.089)    500                262 (0.456)   256 (0.446)   56 (0.098)    574   11.772   0.003
  rs12413409   202 (0.406)   181 (0.364)      114 (0.229)   500                223 (0.389)   273 (0.476)   78 (0.136)    574   21.003   2.75 × 10^− 5^
  rs10953541   343 (0.693)   134 (0.271)      18 (0.036)    500                425 (0.740)   136 (0.237)   13 (0.023)    574   3.759    0.153

AA, wild genotype; AB, heterozygous genotype; BB, homozygous genotype; the number in parenthesis means the frequency of genotypes.

###### 

Genotypic associations of significant SNPs with longevity.

               BB vs. AA   AB vs. AA   AB + BB vs. AA                                                                                         
  ------------ ----------- ----------- ---------------- ---------- -------- ------- -------------- ---------- -------- ------- -------------- ----------
  rs501120     2.412       0.722       0.478--1.090     0.120      13.780   0.469   0.313--0.703   \< 0.001   8.130    0.572   0.389--0.843   0.004
  rs2144300    3.082       0.574       0.036--1.074     0.079      18.332   0.572   0.443--0.740   \< 0.001   19.555   0.572   0.447--0.734   \< 0.001
  rs1864163    12.138      0.277       0.129--0.579     \< 0.001   0.000    0.998   0.740--1.346   0.988      1.389    0.845   0.638--1.119   0.251
  rs2200733    6.976       0.637       0.455--0.891     0.008      0.145    0.942   0.695--1.278   0.756      2.131    0.811   0.612--1.075   0.144
  rs127430     5.506       0.599       0.389--0.921     0.019      10.977   0.496   0.326--0.755   0.001      9.225    0.538   0.359--0.806   0.002
  rs1967017    5.947       0.701       0.527--0.933     0.015      18.496   0.392   0.254--0.607   \< 0.001   15.544   0.599   0.463--0.773   \< 0.001
  rs7193343    0.391       0.870       0.561--1.348     0.574      11.529   0.643   0.498--0.830   0.001      9.862    0.675   0.527--0.863   0.002
  rs12413409   7.427       0.620       0.439--0.875     0.007      5.241    1.366   1.046--1.785   0.025      0.358    1.078   0.843--1.378   0.550

AA, wild genotype; AB, heterozygous genotype; BB, homozygous genotype.

ORs, odds ratios for genotypic contributions of SNPs in the longevity group compared to the control group; 95% CI, 95% confidence interval.

The significance threshold (0.05/3 = 0.017) was corrected by Bonferroni method for multiple comparisons.
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